ALLO Profitability Analysis: Margins, Return on Capital, Free Cash Flow, and More - Allogene Therapeutics Inc

Watchlist Manager

Watchlist

Price: 1.995 USD 0.76%

Market Cap: $688.6m

	Allogene Therapeutics Inc NASDAQ:ALLO	US
	Baoshan Iron & Steel Co Ltd SSE:600019	CN
P	Pushpay Holdings Ltd OTC:PHPYF	NZ
W	W-Scope Chungju Plant Co Ltd KOSDAQ:393890	KR
L	Lennar Corp BMV:LEN	US
P	Persimmon PLC F:OHP	UK
V	VenueG Co Ltd KOSDAQ:019010	KR
R	Rockex Mining Corp CNSX:RXM	CA
Z	Ziga Innovation PCL SET:ZIGA	TH
	Elia Group SA OTC:ELIAF	BE
F	First Pet Life Inc OTC:FPLF	US

Profitability Summary

Allogene Therapeutics Inc's profitability score is Hidden . We take all the information about a company's profitability, such as its margins, capital efficiency, free cash flow generating ability, and more, and consolidate it into one single number: the profitability score. The higher the profitability score, the more profitable the company is.

Low Gross Margin

Low 3Y Average Gross Margin

Negative Operating Margin

-2 893%

Negative 3Y Average Operating Margin

-390 183%

Operating Margin is Increasing

-188 658% > -2 893%

Negative Net Margin

-2 648%

Negative 3Y Average Net Margin

-393 226%

Net Margin is Increasing

-186 679% > -2 648%

Negative Free Cash Flow Margin

-2 211%

Negative 3Y Average Free Cash Flow Margin

-250 517%

Free Cash Flow Margin is Increasing

-127 095% > -2 211%

Negative ROE

-31%

Negative 3Y Average ROE

Negative 3Y Average ROIC

-140%

ROIC is Increasing

-100% > -66%

View All Checks

We take all the information about a company's profitability, such as its margins, capital efficiency, free cash flow generating ability, and more, and consolidate it into one single number: the profitability score. The higher the profitability score, the more profitable the company is.